UNSPSC 51472806: Chlorhexidine dihydrochloride

This classification denotes a topical anti-infective agent with the molecular structure C22H30CL2N10.2CLH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, E64XL9U38K chemically known as 1,1'-hexamethylenebis(5-(p-chlorophenyl)biguanide)dihydrochloride, but more commonly known as chlorhexidine dihydrochloride, which bears US NIH Compound Identifier 9571016. European Medicines Agency schedules Chlorhexidine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11811MIG.

Most nations, for tariff and trade purposes, schedule chlorhexidine dihydrochloride under HS 29252900. SMILES: C1CC(CCC1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2CCC(CC2)CL)CL.CL.CL.

UNSPSC 51472806 Chlorhexidine dihydrochloride is a Commodity code purchasing antimicrobial chemical compounds for use in state and local government facilities, primarily fire departments and public health systems. State and local governments are buying chlorhexidine dihydrochloride as part of broader janitorial, operational, and pharmaceutical supply contracts that serve emergency response and healthcare operations. The issuing bodies include county boards of commissioners and state purchasing alliances managing cooperative purchasing vehicles that aggregate demand across multiple jurisdictions and facilities.

Recent activity shows two distinct procurement tracks. Hillsborough County Board of County Commissioners issued ITB-26-00319 on July 7, 2026, for consumable janitorial and operational supplies with a due date of July 24, 2026 and an estimated contract value of $765,679.84 for one year to support Hillsborough County Fire Rescue Department operations across 47 fire stations. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP (S1070000015802) on January 20, 2026, with a response deadline of March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products distributed across participating state and local government facilities including Oregon, with awarded vendors effective July 1, 2026. Suppliers must be authorized distributors with chain-of-custody capability and compliance certifications including current Good Manufacturing Practices and Drug Supply Chain Security Act adherence; pricing structures are weighted 75 percent in evaluation and must flow through AmerisourceBergen Drug Corporation (Cencora), Cardinal Health, or Morris & Dickson Co., LLC as authorized wholesalers.